Gene: TIMM10B
Official Full Name: translocase of inner mitochondrial membrane 10Bprovided by HGNC
Gene Summary: FXC1, or TIMM10B, belongs to a family of evolutionarily conserved proteins that are organized in heterooligomeric complexes in the mitochondrial intermembrane space. These proteins mediate the import and insertion of hydrophobic membrane proteins into the mitochondrial inner membrane.[supplied by OMIM, Apr 2004]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28066 | TIMM10B Knockout cell line (HeLa) | Human | TIMM10B | 1:3~1:6 | Negative | Online Inquiry |
KO28067 | TIMM10B Knockout cell line (HCT 116) | Human | TIMM10B | 1:2~1:4 | Negative | Online Inquiry |
KO28068 | TIMM10B Knockout cell line (HEK293) | Human | TIMM10B | 1:3~1:6 | Negative | Online Inquiry |
KO28069 | TIMM10B Knockout cell line (A549) | Human | TIMM10B | 1:3~1:4 | Negative | Online Inquiry |
TIMM10B Gene Knockout Cell Lines represent a groundbreaking tool in molecular biology for studying mitochondrial function and biogenesis. These cell lines are specifically engineered to lack the TIMM10B gene, which encodes a component of the mitochondrial import machinery, pivotal for the translocation of nuclear-encoded proteins into mitochondria. By removing this gene, researchers can directly observe the resulting phenotypic characteristics, such as alterations in mitochondrial dynamics, energy production, and overall cellular metabolism.
The key function of TIMM10B is its role in the mitochondrial translocase complex, facilitating the import of essential proteins needed for mitochondrial integrity and function. The lack of TIMM10B results in defective protein importation, leading to disrupted mitochondrial homeostasis and insight into the pathophysiology of various mitochondrial diseases. By utilizing these knockout cell lines, scientists can elucidate the molecular mechanisms underlying mitochondrial dysfunction, paving the way for therapeutic strategies targeting mitochondrial disorders.
In both research and clinical settings, TIMM10B Gene Knockout Cell Lines are invaluable for studying the intricate relationship between mitochondrial impairment and a cadre of diseases including neurodegeneration, metabolic syndromes, and cardiovascular dysfunction. Compared to traditional models, these knockout lines offer a more precise mechanism of action since they eliminate variables associated with other mitochondrial import components.
What sets these knockout cell lines apart from alternatives is their high specificity and reliability in mimicking the pathological states associated with TIMM10B dysfunction. Researchers benefit from the opportunity to develop targeted therapies and screening of compounds that support mitochondrial health.
By investing in TIMM10B Gene Knockout Cell Lines, researchers and clinicians are equipped with an innovative tool that not only enhances their understanding of mitochondrial biology but also accelerates the discovery of new treatment avenues for mitochondrial diseases. Our company prides itself on producing high-quality, rigorously validated biological products, ensuring that scientists can conduct their research with confidence and precision.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.